SCHEMBL15480223

SCHEMBL15480223

c1ccc(-n2c3ccccc3c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4cccc(-c5cccc6ccccc56)c4)cc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ MCL1 Q07820 1/20 0.39
▸ ACMSD Q8TDX5 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ NTSR1 P30989 2/20 0.36
▸ MAPT P10636 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ TLR4 O00206 1/20 0.35
▸ MAPK14 Q16539 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ IL1R1 P14778 1/20 0.34
▸ TUBB4A P04350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15480227 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL16727264 1.00 L3MBTL1 (0.45) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL25941661 0.98 KDM4E (0.43) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL23370405 0.96 L3MBTL1 (0.49) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL23370387 0.96 KDM4E (0.49) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL23370519 0.96 KDM4E (0.49) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL21151636 0.96 L3MBTL1 (0.49) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL23370609 0.96 KDM4E (0.49) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL25941131 0.95 KDM4E (0.43) L3MBTL1KDM4EATMMCL1ACMSD
SCHEMBL16171567 0.95 KDM4E (0.45) L3MBTL1KDM4EATMMCL1ACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210151683-A1 LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME TORAY INDUSTRIES, INC. (JP) 2021-05-20 — — US disclosed
US-20160268517-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-09-15 — — US disclosed
US-20160268517-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-09-15 — — US disclosed
US-20150249219-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-09-03 — — US disclosed
US-20150249219-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-09-03 — — US disclosed
US-20140048784-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2014-02-20 — — US disclosed
US-20140048784-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2014-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160268517-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, CCNT1, CCNA1 L3MBTL1 30/4885KDM4E 2191/4885ATM 4082/4885
US-20150249219-A1 BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, CCNT1, CCNA1 L3MBTL1 29/4885KDM4E 2205/4885ATM 4082/4885
US-20210151683-A1 LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME CBR3, INTS9, CBR1 L3MBTL1 208/4885KDM4E 1196/4885ATM 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback